InvestorsHub Logo
Followers 18
Posts 943
Boards Moderated 0
Alias Born 03/23/2011

Re: trader22 post# 105064

Saturday, 07/19/2014 12:59:48 AM

Saturday, July 19, 2014 12:59:48 AM

Post# of 130507
What is this anyway?

Quote:
"Amarantus has been working alongside Beckman-Coulter, a labotatory diagnostics supply company. It is rumored that an acquisition of AMBS by Beckman-Coulter is a possibility, given the clinical success of LymPro. Beckman-Coulter appears to have the finances, ability, and incentive to do so.
Beckman-Coulter greatly increased the efficiency of the diagnostic Complete Blood Count. At the time, the Coulter method swept laboratories across the world, given that it automated a test which otherwise had to be manually counted by lab technicians.

"

End Quote


Ref:
https://stockwiki.org/index.php/Ambs

Disclaimer
I do not proclaim that this is true or accurate,
I found it on the internet and I have no idea
whether its true or false. I would error on false
because buyout rumors are not very accurate.